Benzinga's Top Initiations - Boundless Bio (NASDAQ:BOLD)

Ascendiant Capital Markets initiated coverage on MGT Capital Investments Inc. MGT with a Buy rating. The price target for MGT Capital Investments is set to $6. MGT Capital Investments shares rose 5.35 percent to $3.35 in pre-market trading.
Analysts at Goldman Sachs initiated coverage on Lifelock Inc LOCK with a Neutral rating. The price target for Lifelock is set to $18. Lifelock shares rose 0.18 percent to close at $17.06 on Friday.
Wedbush initiated coverage of Audentes Therapeutics Inc BOLD with an Outperform rating. The price target for Audentes Therapeutics is set to $20. Audentes Therapeutics shares fell 1.80 percent to close at $14.70 on Friday.
Analysts at Needham initiated coverage on IMPINJ Inc PI with a Buy rating. IMPINJ shares gained 7.56 percent to $21.48 in pre-market trading.
Analysts at Raymond James initiated coverage on Patheon NV PTHN with an Outperform rating. The price target for Patheon is set to $32.50. Patheon shares gained 1.85 percent to $27.50 in pre-market trading.
Analysts at Wells Fargo initiated coverage on AdvancePierre Foods Holdings Inc APFH with an Outperform rating. AdvancePierre Foods shares closed at $24.97 on Friday.
Analysts at JP Morgan initiated coverage of Diebold Inc DBD with a Neutral rating. Diebold shares closed at $28.17 on Friday.
Analysts at Cowen & Company initiated coverage on GlycoMimetics Inc GLYC with an Outperform rating. GlycoMimetics shares closed at $8.02 on Friday.
Analysts at Morgan Stanley assumed Symantec Corporation SYMC with an Overweight rating. The price target for Symantec is set to $27. Symantec shares closed at $22.54 on Friday.
RBC Capital initiated coverage on IMPINJ Inc PI with an Outperform rating. IMPINJ shares gained 7.56 percent to $21.48 in pre-market trading.

Market News and Data brought to you by Benzinga APIs